Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Soleno Therapeutics stock have a consensus rating of "Buy" and an average price target of $74.14, which forecasts a 40.23% increase in the stock price over the next year. The lowest target is $53 and the highest is $121.

Price Target: $74.14 (+40.23%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$53	$74.14	$53	$121
Change	+0.25%	+40.23%	+0.25%	+128.86%

Analyst Ratings

The average analyst rating for Soleno Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	5	5	1	1
Buy	6	6	6	6	3	2
Hold	0	0	0	0	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	11	11	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Derek Archila Wells Fargo	Wells Fargo	Buy → Hold Downgrades $110 → $53	Buy → Hold	Downgrades	$110 → $53	+0.25%	Apr 17, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades $100 → $53	Strong Buy → Hold	Downgrades	$100 → $53	+0.25%	Apr 8, 2026
Tyler Van Buren TD Cowen	TD Cowen	Strong Buy → Hold Downgrades $85 → $53	Strong Buy → Hold	Downgrades	$85 → $53	+0.25%	Apr 7, 2026
Kalpit Patel Wolfe Research	Wolfe Research	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Apr 7, 2026
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy → Hold Downgrades $123 → $53	Buy → Hold	Downgrades	$123 → $53	+0.25%	Apr 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

476.88M

Increased by 150.46%

from 190.41M

Revenue Next Year

717.10M

Increased by 50.37%

from 476.88M

EPS This Year

3.97

Increased by 917.38%

from 0.39

EPS Next Year

6.69

Increased by 68.66%

from 3.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	190.41M	476.88M	717.10M
Revenue Growth	-	-	-	-	-	150.46%	50.37%
EPS	-5.81	-2.87	-2.36	-4.38	0.39	3.97	6.69
EPS Growth	-	-	-	-	-	917.38%	68.66%
Forward PE	-	-	-	-	-	13.32	7.90
No. Analysts	-	-	-	-	-	15	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	544.7M	866.3M
Avg	476.9M	717.1M
Low	425.0M	528.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	186.1%	81.6%
Avg	150.5%	50.4%
Low	123.2%	10.8%

EPS Forecast

EPS	2026	2027	2028
High	5.83	10.42
Avg	3.97	6.69
Low	2.64	3.65

EPS Growth

EPS Growth	2026	2027	2028
High	1,394.2%	162.5%
Avg	917.4%	68.7%
Low	575.9%	-8.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.